Cargando…
2523 Noninvasive biomarkers for inflammatory bowel disease: Drawbacks and potential
OBJECTIVES/SPECIFIC AIMS: Approximately 1.6 million Americans suffer from inflammatory bowel diseases (IBD), ulcerative colitis, and Crohn’s disease. It is a challenge for both physicians and patients alike to manage the disease, primarily due to lack of disease specific biomarkers. Endoscopy remain...
Autores principales: | Patel, Vihang, Seif, Sherif, Barrett, Terrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799633/ http://dx.doi.org/10.1017/cts.2018.102 |
Ejemplares similares
-
3253 Identification of Immune Cell Profiles and Molecular Pathways in Inflammatory Bowel Disease Driving Non-Response to Biologic Therapy
por: Penrose, Harrison Michael, et al.
Publicado: (2019) -
2126 Optimizing a technique for visualizing retinal and choroidal blood flow noninvasively
por: Vora, Paras, et al.
Publicado: (2018) -
2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018) -
2342 Protein production as an early pharmacodynamics biomarker for RNA-targeting therapies
por: Self, Wade K., et al.
Publicado: (2018) -
2329 Associations between inflammatory markers and negative symptoms in individuals with schizophrenia: Converging evidence
por: Goldsmith, David, et al.
Publicado: (2018)